Members of opposition TMC and NCP on Thursday sought to know from the government its stand on booster doses for COVID-19, besides usage of money from the PM-CARES funds.
Participating in a discussion on the COVID-19 pandemic in Lok Sabha, TMC member Saugata Roy accused the political leadership of "complacency" in handling of the pandemic.
He said it is because of the "mistakes" at the top level of the government that the country was caught "unprepared" in both the waves of COVID-19.
"Till today, I do not know about what happened to other vaccines that have been discovered in the world -- Pfizer, Moderna, Johnson & Johnson. Whether all these vaccines have come to India and whether they can be used?" he said.
Is a booster dose necessary, Roy asked and added that the Indian Council of Medical Research (ICMR) has not issued any directive yet.
NCP's Supriya Sule said states have also contributed to the PM-CARES fund, and sought to know how the Centre is distributing the money to states.
"What is your stand on the third dose? We all have ageing parents, families, health workers ... they all are anxious because there is no clarity," she said, asking the government to also make it clear that booster and third dose are the same.
Ritesh Pandey (BSP) accused the government of "leadership failure" in handling the pandemic and said in India less than one per cent of RT-PCR tests are sent for genome sequencing, which is the lowest among G-20 countries.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)